PSYC Makes Oregon New Headquarters for Executive Office and Future Expansion
- Tech pulls Nasdaq, S&P 500 down as Treasury yields rise
- Merck (MRK) Said to Be Unidentified Suitor for Acceleron Pharma (XLRN), Not Bristol-Myers Squibb (BMY) - Report
- EV Company Polestar To Go Public Via $20 Billion SPAC Deal
- Amazon (AMZN) Price Target Lowered at Morgan Stanley Amid Rising Logistics Workforce Costs, Analyst Expects Stock to be Range Bound in Near Term
- Oil up on tight supply, Brent crude nears $80 a barrel
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Global Trac Solutions, Inc. Makes the Move to the First State in America to Legalize Psilocybin
LAKE OSWEGO, OR, April 14, 2021 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) the first publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to announce the Company has relocated its executive and company headquarters from Las Vegas, NV, to the state of Oregon, which, the Company contends, has emerged in recent months as a fundamental state in the US for the development and expansion of the medicinal psychedelic industry.
With the successful passage of Measure 109 last November by Oregon voters, the state is poised to become the first in the nation to develop and implement a state-regulated psilocybin therapy program for residents suffering from specific clinical and treatment-resistant mental health conditions such as depression, anxiety, PTSD, and addiction.
The Company, along with the medicinal psychedelics industry, believe that the state’s psilocybin therapy program has the potential to play a pivotal role in paving an effective path for medicinal psychedelics and their inclusion in mental health therapy programs in the coming years across the nation.
“I am very excited to complete this strategic relocation of Global Trac’s executive headquarters,” Said Global Trac Solutions, Inc. CEO, David Flores. “My intent is very much to make this relocation to the state of Oregon a very significant part of the new chapter we are in the process of writing for PSYC within the medicinal psychedelic industry. As PSYC becomes further immersed within this space and continues to establish itself as the leading source for news, information, and premium original content, I can’t think of a better location within the US to begin laying roots down for the Company.”
For the better part of the past decade, the Company’s primary headquarters have been in both San Diego, CA, and Las Vegas, NV. And now, as the Company pushes forward with what has to-date been a successful transition into the burgeoning medicinal psychedelic industry, it will look to further solidify its presence and expand its growing network within the sector by establishing a home base in Lake Oswego, OR.
“Much like the industry itself, PSYC is at the very beginning of its growth and evolution,” said Flores. “Guiding our company into the most effective and favorable position possible to capitalize on the growth of this industry while continuing to be an important voice and ally for it remains my number one objective. And with Oregon emerging as a leader in the rollout of medicinal psychedelic treatments, I look forward to remaining vigilant and aggressive in our approach to identifying value-driven opportunities for PSYC.”
About Global Trac Solutions, Inc. (OTCPink: PSYC)
At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.
We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.
Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)
- Bombardier’s Flagship Global 7500 and Best-selling Challenger 350 Business Jets on Display in Europe
- ComplyAdvantage Releases State Of Financial Crime 2021 Mid-Year Review
Create E-mail Alert Related CategoriesGlobe Newswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!